Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Crohn's Disease”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Testing effectiveness (Phase 2)Study completedNCT00267722
What this trial is testing

Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease

Who this might be right for
Crohn's Disease
Facet Biotech 18
Early research (Phase 1)Ended earlyNCT03169894
What this trial is testing

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Avalo Therapeutics, Inc. 8
Post-approval studies (Phase 4)WithdrawnNCT02760615
What this trial is testing

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda
Large-scale testing (Phase 3)Study completedNCT02611817
What this trial is testing

Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
Takeda 644
Testing effectiveness (Phase 2)Ended earlyNCT04102111
What this trial is testing

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 48
Large-scale testing (Phase 3)Study completedNCT02914561
What this trial is testing

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Lakefront Biotherapeutics NV 1,372
Testing effectiveness (Phase 2)Looking for participantsNCT06548542
What this trial is testing

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 540
Large-scale testing (Phase 3)Study completedNCT00409682
What this trial is testing

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Abbott 192
Post-approval studies (Phase 4)Looking for participantsNCT06581328
What this trial is testing

Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 200
Large-scale testing (Phase 3)Study completedNCT03782376
What this trial is testing

Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen-Cilag Ltd. 215
Not applicableAvailableNCT06856135
What this trial is testing

Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda
Testing effectiveness (Phase 2)Study completedNCT02378688
What this trial is testing

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 78
Testing effectiveness (Phase 2)Study completedNCT00072943
What this trial is testing

A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's DiseaseColitisIntestinal Disease+2 more
Facet Biotech 175
Large-scale testing (Phase 3)Study completedNCT03234907
What this trial is testing

Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

Who this might be right for
Crohn's Disease
Takeda 215
Testing effectiveness (Phase 2)Ended earlyNCT01009281
What this trial is testing

An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's DiseaseInflammatory Bowel Disease
Novartis Pharmaceuticals 7
Testing effectiveness (Phase 2)Study completedNCT00042055
What this trial is testing

CP-461 for the Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Astellas Pharma Inc 30
Large-scale testing (Phase 3)Ended earlyNCT03627091
What this trial is testing

Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)

Who this might be right for
Crohn's Disease
Shire 40
Large-scale testing (Phase 3)Looking for participantsNCT06100289
What this trial is testing

Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 70
Testing effectiveness (Phase 2)Study completedNCT00603616
What this trial is testing

Induction of Clinical Response Using Rifaximin in Crohn's Disease

Who this might be right for
Crohn's Disease
Scott Lee 36
Large-scale testing (Phase 3)Looking for participantsNCT06430801
What this trial is testing

Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Who this might be right for
Crohn's Disease
Merck Sharp & Dohme LLC 1,200
Next Page